Completed PHASE1 INTERVENTIONAL 2-arm NCT02527005

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients

A Comparative Study of Azithromycin and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant HIV Positive Patients

Sponsor: University of Ibadan

Conditions HIV Malaria Pregnant

Interventions Azithromycin Sulphadoxine-pyrimethamine

Updated 8 times since 2017 Last updated: Dec 7, 2017 Started: Sep 30, 2015 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates HIV and Malaria and is currently completed. University of Ibadan leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Dec 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Sep 2017 — Dec 2017 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Feb 2017 — Sep 2017 [monthly]

Not Yet Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Ibadan

Data source: University of Ibadan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ibadan, Nigeria